Heart Attack (Myocardial Infarction) News and Research

RSS

A Heart Attack (Myocardial Infarction) occurs when blood flow to a section of heart muscle becomes blocked. If the flow of blood isn’t restored quickly, the section of heart muscle becomes damaged from lack of oxygen and begins to die.

Heart attack is a leading killer of both men and women in the United States. But fortunately, today there are excellent treatments for heart attack that can save lives and prevent disabilities. Treatment is most effective when started within 1 hour of the beginning of symptoms. Heart attacks occur most often as a result of a condition called coronary artery disease (CAD). In CAD, a fatty material called plaque (plak) builds up over many years on the inside walls of the coronary arteries (the arteries that supply blood and oxygen to your heart). Eventually, an area of plaque can rupture, causing a blood clot to form on the surface of the plaque. If the clot becomes large enough, it can mostly or completely block the flow of oxygen-rich blood to the part of the heart muscle fed by the artery.

Diabetes risk down three times with newer hypertension drugs

According to researchers patients given a mix of modern blood pressure drugs are one-third less likely to develop diabetes than those on older pills.

7 Sep 2006

UIC receives $20 million NCI grant to research blood disorders

A $19.6 million National Cancer Institute grant has been awarded to the University of Illinois at Chicago College of Medicine to advance basic and clinical research for incurable blood disorders.

6 Sep 2006

Ultrasound targets angioplasty

World Congress of Cardiology 2006 - A simple technique - combining cardiac ultrasound with a heart muscle-stimulating drug - can identify the MI patients who would benefit most from angioplasty after thrombolysis, reports a study in Hot Line session II.

6 Sep 2006

Identifying international differences in outcomes among patients with atherothrombotic disease may enhance strategies for risk reduction and prevention

World Congress of Cardiology Report - The Reduction of Atherothrombosis for Continued Health (REACH) Registry investigators have released preliminary two-year outcomes data from this international, observational study which shows high rates of atherothrombotic events on a worldwide basis.

5 Sep 2006

Test on viability of heart muscle identifies patients who will benefit from angioplasty after clot-lysing therapy for an acute heart attack

Emergency angioplasty (balloondilation of the coronary vessel) is the preferred treatment for patients with an acute heart attack. Because of its limited availability worldwide, the majority of patients who are admitted to the hospital with a heart-attack are treated with clot-lysing drugs (thrombolysis).

5 Sep 2006

Preventing bleeding is key to the treatment of acute coronary syndromes

On Monday, September 4 and Tuesday, September 5 at the World Congress of Cardiology, Dr. Christopher Granger presented data stressing the importance of prevention of bleeding as a key objective in treatment of acute coronary syndromes.

5 Sep 2006

Simple bedside test may identify heart attack risk

The reason behind why patients who are on aspirin still have heart attacks is an important topic in cardiovascular disease.

5 Sep 2006

How effective is continued Plavix therapy in patients undergoing a repeat stent procedure?

Clopidogrel (Plavix) is used worldwide in millions of patients after placement of coronary artery stents. Sales of the drug exceed 5 billion US dollars.

5 Sep 2006

One of the largest Japanese cardiovascular trials confirms angiotensin receptor blockade protects people who have a wide range of cardiovascular diseases

The first controlled large-scale intervention trial of angiotensin receptor blockade in Japanese patients has confirmed that the cardiovascular protective effects of the drug valsartan is greater than to those seen with other therapies giving the same level of blood pressure control.

5 Sep 2006

New drug improves blood flow in diseased arteries

A new drug has been shown to improve blood flow in diseased arteries, reducing the risk of high blood pressure and heart attacks, a Monash University study published today reveals.

4 Sep 2006

Improvements needed in China heart care

Inequitable and cost-inefficient allocation of scarce resources has been found to be a key problem in the management of heart attack and severe angina patients in China, according to the results of a study announced today at the World Congress of Cardiology in Barcelona, Spain.

4 Sep 2006

Eastern Europe, Middle East has highest rates of cardiovascular disease deaths

Eastern European and Middle Eastern patients with diseased blood vessels have the highest rates of heart attacks and strokes, and the highest rates of death from those conditions, compared with similar patients in other regions of the world.

4 Sep 2006

U.S. health care system offers good value in terms of life expectancy gains despite rising costs

U.S. residents have benefited from increases in health care costs since 1960 through increased life expectancy, according to a study published on Thursday in the New England Journal of Medicine, the AP/Seattle Post-Intelligencer reports.

1 Sep 2006

Omega-3 fatty acids may prevent more sudden deaths than defibrillators

Omega-3 fatty acids may prevent more sudden deaths than automated external defibrillators in homes and public places or implanted defibrillators, according to the results of a new study.

31 Aug 2006

Most effective treatments for people with coronary artery disease

Medication, angioplasty or surgery? For some heart disease patients, there's no clear-cut choice. The key to getting the best care is to follow your individual doctor's advice, new research shows.

31 Aug 2006

Women's Health Network petitions FDA to halt sales of estrogen, testosterone combination treatments

The National Women's Health Network has petitioned FDA to stop sales of Solvay's Estratest and Breckenridge Pharmaceuticals' Syntest, which are estrogen-testosterone combination therapies used to treat menopause-associated hot flashes, until they are proven safe and effective, Reuters reports.

24 Aug 2006

No matter how you do it tobacco is a killer

Regardless of how you do it, smoked or chewed, firsthand or secondhand, it seems all kinds of tobacco cause heart attacks.

21 Aug 2006

BMI unreliable when assessing obesity and risk of heart disease

According to doctors in the United States the standard measure of obesity, the Body Mass Index (BMI), is badly flawed and may not be such an accurate indicator as it lumps muscle and fat into one category.

21 Aug 2006

All forms of tobacco use or exposure are harmful

All forms of tobacco exposure - smoking, chewing or inhaling second hand smoke - increase the risk of heart attack up to three times, according to an Article in this week’s issue of The Lancet.

17 Aug 2006

FDA approves Plavix for STEMI heart attacks

The Food and Drug Administration (FDA) today approved the use of Plavix (clopidogrel bisulfate) for patients who have had a type of heart attack called acute ST-segment elevation myocardial infarction (STEMI), who are not going to have coronary artery repair (angioplasty).

17 Aug 2006